🔴 Immunic is trading 5% down with no clear company-specific catalyst

Immunic is trading at $9.02, down 5.15%, with no clear Immunic-specific catalyst identified for the September 29 decline.

• The company’s latest listed release was its September 2 R&D Day announcement.
• Broader equities and healthcare were under pressure, but reported index moves were mixed and modest and do not establish the cause of Immunic’s larger drop.